Cellink Ab Stock Last Dividend Paid
| 49Z Stock | EUR 2.67 0.08 2.91% |
Cellink AB fundamentals help investors to digest information that contributes to Cellink AB's financial success or failures. It also enables traders to predict the movement of Cellink Stock. The fundamental analysis module provides a way to measure Cellink AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cellink AB stock.
Cellink |
Cellink AB Company Last Dividend Paid Analysis
Cellink AB's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Cellink AB has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Devices (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Cellink Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellink AB's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cellink AB could also be used in its relative valuation, which is a method of valuing Cellink AB by comparing valuation metrics of similar companies.Cellink AB is currently under evaluation in last dividend paid category among its peers.
Cellink Fundamentals
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0245 | |||
| Profit Margin | (0.34) % | |||
| Current Valuation | 725.81 M | |||
| Shares Outstanding | 69.07 M | |||
| Shares Owned By Insiders | 38.50 % | |||
| Shares Owned By Institutions | 26.73 % | |||
| Price To Book | 0.91 X | |||
| Price To Sales | 3.42 X | |||
| Revenue | 1.26 B | |||
| Gross Profit | 1.83 B | |||
| EBITDA | 37.7 M | |||
| Net Income | (227.6 M) | |||
| Total Debt | 1.35 B | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 6.91 X | |||
| Cash Flow From Operations | (409.2 M) | |||
| Earnings Per Share | 0.07 X | |||
| Number Of Employees | 1.21 K | |||
| Beta | 2.1 | |||
| Market Capitalization | 450.38 M | |||
| Total Asset | 9.75 B | |||
| Net Asset | 9.75 B |
About Cellink AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cellink AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellink AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellink AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Cellink Stock
Cellink AB financial ratios help investors to determine whether Cellink Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cellink with respect to the benefits of owning Cellink AB security.